Berry Genomics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 1,448

Employees

  • Stock Symbol
  • 000710

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.76
  • (As of Monday Closing)

Berry Genomics General Information

Description

Berry Genomics Co Ltd is a biotechnology company. It providess gene sequencing detection equipment and services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Building 5, Yard 4, Shengshengyuan Road
  • Science and Technology Park, Changping District
  • Beijing
  • China
+86 010
Primary Industry
Biotechnology
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Building 5, Yard 4, Shengshengyuan Road
  • Science and Technology Park, Changping District
  • Beijing
  • China
+86 010

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Berry Genomics Stock Performance

As of 17-Feb-2025, Berry Genomics’s stock price is $1.76. Its current market cap is $624M with 354M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.76 $1.60 $0.89 - $1.83 $624M 354M 20.7M -$0.11

Berry Genomics Financials Summary

As of 30-Sep-2024, Berry Genomics has a trailing 12-month revenue of $154M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 423,599 585,411 593,364 1,091,755
Revenue 154,425 162,747 203,133 220,251
EBITDA (42,479) (46,046) (23,517) (871)
Net Income (39,266) (60,382) (36,963) (18,068)
Total Assets 362,132 386,700 464,322 551,273
Total Debt 16,324 42,826 50,465 62,644
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Berry Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Berry Genomics‘s full profile, request access.

Request a free trial

Berry Genomics Patents

Berry Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4400637-A1 Method for constructing capture library having high test performance, and kit Pending 09-Sep-2021
US-20220348911-A1 Method to construct whole-genome high-throughput sequencing library and test kit thereof Pending 29-Dec-2020
US-20220348996-A1 Method and kit for non-specific amplification of natural short-fragment nucleic acid Pending 02-Aug-2019
US-20220251549-A1 Method for constructing capture library and kit Pending 25-Jul-2019
US-20220298505-A1 Method for constructing pacbio sequencing library Pending 26-Jun-2019 C12N15/1093
To view Berry Genomics’s complete patent history, request access »

Berry Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Berry Genomics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Berry Genomics‘s full profile, request access.

Request a free trial

Berry Genomics Investments (2)

Berry Genomics’s most recent deal was a Early Stage VC with Belief BioMed for . The deal was made on 19-Jun-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Belief BioMed 19-Jun-2018 Early Stage VC Drug Discovery
Sanomics Later Stage VC Biotechnology
To view Berry Genomics’s complete investments history, request access »

Berry Genomics ESG

Risk Overview

Risk Rating

Updated January, 20, 2021

31.54 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,042

Rank

Percentile

Pharmaceuticals

Industry

of 193

Rank

Percentile

Biotechnology

Subindustry

of 165

Rank

Percentile

To view Berry Genomics’s complete esg history, request access »

Berry Genomics Exits (1)

Berry Genomics’s most recent exit was on 19-Jun-2018 from Belief BioMed. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Belief BioMed 19-Jun-2018 Completed
  • 3 buyers
To view Berry Genomics’s complete exits history, request access »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Berry Oncology Fuzhou, China 2017

Berry Genomics FAQs

  • When was Berry Genomics founded?

    Berry Genomics was founded in 2010.

  • Where is Berry Genomics headquartered?

    Berry Genomics is headquartered in Beijing, China.

  • What is the size of Berry Genomics?

    Berry Genomics has 1,448 total employees.

  • What industry is Berry Genomics in?

    Berry Genomics’s primary industry is Biotechnology.

  • Is Berry Genomics a private or public company?

    Berry Genomics is a Public company.

  • What is Berry Genomics’s stock symbol?

    The ticker symbol for Berry Genomics is 000710.

  • What is the current stock price of Berry Genomics?

    As of 17-Feb-2025 the stock price of Berry Genomics is $1.76.

  • What is the current market cap of Berry Genomics?

    The current market capitalization of Berry Genomics is $624M.

  • What is Berry Genomics’s current revenue?

    The trailing twelve month revenue for Berry Genomics is $154M.

  • What is Berry Genomics’s annual earnings per share (EPS)?

    Berry Genomics’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »